Atlas Trials

A Study of Tirzepatide (LY3298176) in Healthy Participants

Clinical trial NCT03375463 · COMPLETED

Trial details

NCT number
NCT03375463
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-12-19
Primary completion
2018-12-27
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.